Toll-like receptor 3 gene expression in Egyptian patients with glomerulonephritis and hepatitis C virus infection

References

• Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, El Khoby T, Abdel-Wahab Y, Aly Ohn ES, Anwar W, Sallam I. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000;355:887–91.
   PubMed Web of Science ®Google Scholar
• Lehman EM, Wilson ML. Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality. J Viral Hepat 2009;16:650–8.
   PubMed Web of Science ®Google Scholar
• Strickland GT. Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. Hepatology 2006;43:915–22.
   PubMed Web of Science ®Google Scholar
• Sterling RK, Bralow S. Extrahepatic manifestations of hepatitis C virus. Curr Gastroenterol Rep 2006;8:53–9.
   PubMedGoogle Scholar
• Perico N, Cattaneo D, Bikbov B, Remuzzi G. Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol 2009;4:207–20.
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001;2:675–80.
   PubMed Web of Science ®Google Scholar
• Alexopoulou, L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-KB by Toll-like receptor 3. Nature 2001;413:732–8.
   PubMed Web of Science ®Google Scholar
• Zarember KA, Godowski PJ. Tissue expression of toll-like receptors and differential regulation of toll-like receptor mRNAs in leucocytes in response to microbes, their products and cytokines. J Immunol 2002;168;554–61.
   PubMed Web of Science ®Google Scholar
• Tsuboi N, Yoshikai Y, Matsuo S, Kikuchi T, Iwami K, Nagai Y, Takeuchi O, Akira S, Matsuguchi T. Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol 2002;169: 2026–33.
   PubMed Web of Science ®Google Scholar
• Ebihara T, Shingai M, Matsumoto M, Wakita T, Seya T. Hepatitis C virus-infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells. Hepatology 2008;48:48–58.
   PubMed Web of Science ®Google Scholar
• Antonelli A, Ferri C, Ferrari SM, Ghiri E, Goglia F, Pampana A, Bruschi F, Fallahi P. Serum levels of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor alpha in mixed cryoglobulinemia. Arthritis Rheum 2009;60:3841–7.
   PubMed Web of Science ®Google Scholar
• Targett-Adams P, Boulant S, McLauchlan J. Visualization of double-stranded RNA in cells supporting hepatitis C virus RNA replication. J Virol 2008;82:2182–95.
   PubMed Web of Science ®Google Scholar
• Dolganiuc A, Garcia C, Kodys K, Szabo G. Distinct toll-like receptor expression in monocytes and T cells in chronic HCV infection. World J Gastroenterol 2006;12: 1198–204.
   PubMed Web of Science ®Google Scholar
• Taylor MW, Tsukahara T, Brodsky L, Schaley J, Sanda C, Stephens MJ, McClintick JN, Edenberg HJ, Li L, Tavis JE, Howell C, Belle SH. Changes in gene expression during peginterferon and ribavirin therapy of chronic hepatitis C distinguish responders from non responders to antiviral therapy. J Virol 2007;81:3391–401.
   PubMed Web of Science ®Google Scholar
• Wornle M, Schmid H, Banas B, Merkle M, Henger A, Roeder M, Blattner S, Bock E, Kretzler M, Gröne HJ, Schlöndorff D. Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol 2006;168: 370–85.
   Google Scholar
• Winfield JB, Koffler D, Kunkel HG. Specific concentration of polynucleotide immune complexes in the cryoprecipitates of patients with systemic lupus erythematosus. J Clin Invest 1975;56:563–70.
   PubMed Web of Science ®Google Scholar
• Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996;6:986–94.
   PubMed Web of Science ®Google Scholar
• Sabry AA, Sobh MA, Irving WL, Grabowska A, Wagner BE, Fox S, Kudesia G, El-Nahas AM. A comprehensive study of the association between hepatitis C virus and glomerulopathy. Nephrol Dial Transplant 2002;17:239–45.
   PubMed Web of Science ®Google Scholar
• Cao Y, Zhang Y, Wang S, Zou W. Detection of the hepatitis C virus antigen in kidney tissue from infected patients with various glomerulonephritis. Nephrol Dial Transplant 2009; 24:2745–51.
   PubMed Web of Science ®Google Scholar
• Hestin D, Guillemin F, Castin N, Le Faou A, Champigneulles J, Kessler M. Pretransplant hepatitis C virus infection: a predictor of proteinuria after renal transplantation. Transplantation 1998;65:741–4.
   PubMed Web of Science ®Google Scholar
• Coccoli R, Esposito R, Cianciaruso B, Pota A, Visciano B, Annecchini R, Parrilli G. Hepatitis C and kidney disease. Dig Liver Dis 2007;39(Suppl. 1):S83–5.
   Google Scholar
• Unterholzner L, Bowie AG. The interplay between viruses and innate immune signaling: recent insights and therapeutic opportunities. Biochem Pharm 2008;75:589–602.
   PubMed Web of Science ®Google Scholar
• Schmidt KN, Leung B, Kwong M, Zarember KA, Satyal S, Navas TA, Wang F, Godowski PJ. APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. J Immunol 2004;172:138–43.
   PubMed Web of Science ®Google Scholar
• Atencia R, Bustamante FJ, Valdivieso A, Arrieta A, Rinon M, Prada A, Maruri N. Differential expression of viral PAMP receptors mRNA in peripheral blood of patients with chronic hepatitis C infection. BMC Infectious Dis 2007; 7:136. doi:10.1186/1471-2334-7-136
   PubMed Web of Science ®Google Scholar
• Echeverria I, Zabaleta A, Silva L, Díaz-Valdés N, Riezu-Boj JI, Lasarte JJ, Borrás-Cuesta F, Civeira MP, Prieto J, Sarobe P. Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C). J Viral Hepat 2008;15:782–9.
   PubMed Web of Science ®Google Scholar
• Miyazaki M, Kanto T, Inoue M, Itose I, Miyatake H, Sakakibara M, Yakushijin T, Kakita N, Hiramatsu N, Takehara T, Kasahara A, Hayashi N. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I. J Med Virol 2008;80:980–8.
   PubMed Web of Science ®Google Scholar
• Dolganiuc A, Kodys K, Kopasz A, Marshall C, Do T, Romics L Jr, Mandrekar P, Zapp M, Szabo G. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J Immunol 2003;170:5615–24.
   PubMedGoogle Scholar
• Gale M, Foy EM. Evasion of intracellular host defence by hepatitis C virus. Nature 2005;436:939–45.
   PubMed Web of Science ®Google Scholar
• Li K, Foy E, Ferreon JC, Nakamura M, Ferreon ACM, Ikeda M, Gale M, Lemon SM. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA 2005;102:2992–7.
   PubMed Web of Science ®Google Scholar
• Alpers CE, Smith KD. Cryoglobulinemia and renal disease. Curr Opin Nephrol Hypertens 2008;17:243–9.
   PubMed Web of Science ®Google Scholar
• Sabry A. Proteinuria among renal transplant patients and its relation to hepatitis C Virus and graft outcome: a single center experience. Exp Clin Transplant 2010;8:91–7.
   PubMed Web of Science ®Google Scholar
• Trendelenburg M, Schifferli JA. Cryoglobulins in chronic hepatitis C virus infection. Clin Exp Immunol 2003;133:275–82.
   PubMed Web of Science ®Google Scholar
• Fabrizi F, Lunghi G, Messa P, Martin P. Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. J Nephrol 2008;21:813–25.
   PubMed Web of Science ®Google Scholar